Reps. Murphy, Peters, Rush, Dunn Introduce Bipartisan Legislation to Expand Access to Lifesaving Diagnostics for Medicare Beneficiaries

July 16, 2021
Press Release

Washington, D.C. – Today, Reps. Greg Murphy, M.D. (NC-03), Scott Peters (CA-52), Bobby L. Rush (IL-01), and Neal Dunn (FL-02) introduced the Facilitating Innovative Nuclear Diagnostics (FIND) Act to expand patient access to advanced nuclear diagnostic imaging technology. Medicare’s reimbursement plan limits patient access to new and innovative imaging tools that can be used to improve diagnosis of life-threatening diseases. The FIND Act would eliminate these barriers by providing physicians and patients with more complete diagnostic options to improve health care outcomes and save lives.

“I am proud to co-lead this lifesaving legislation,” said Murphy. “As a physician, I have used diagnostic radiopharmaceuticals in my practice, and I have seen the significant health care benefits of this groundbreaking medical technology. It is critical that we change the Medicare reimbursement structure to allow increased access to these important diagnostic imaging tools for the most at-risk populations. Early diagnosis and treatment have been proven to improve health care outcomes, save lives, and lower the cost of medical treatments for patients. I urge my colleagues in the House to support our common-sense, bipartisan bill.”

“In San Diego and across the country, health care innovation has allowed doctors to diagnose, monitor, and treat some of the most aggressive and least understood diseases. Expanding access and affordability to these resources is critical,” said Peters. “Our bill will provide doctors with radiopharmaceutical diagnostic tools to help their patients find the answers they need to effectively and efficiently treat their illnesses.”

“America leads the world in medical research and innovation – but far too often, patients are unable to access the benefits of innovative medical technologies because of outdated Medicare reimbursement policy,” said Dunn. “The FIND Act is a common-sense, bipartisan proposal to address these current reimbursement problems, giving patients access to the diagnostic tools they need, when they need them. Early detection saves lives, and we must do what we can to expand access to these life-saving tools.”

“We cannot tolerate a two-tiered health care system — one for the rich, and one for everyone else. Unfortunately, many low-income and minority patients are being denied access to the most efficient tests, therapies, and care due to the current payment structure for diagnostic radiopharmaceuticals that makes it nearly impossible for many hospitals serving our most vulnerable populations to offer these life-saving diagnostics. The FIND Act is important legislation to help fix this disparity,” said Rush. “Alzheimer’s disease, prostate cancer, and other life-altering conditions have a disproportionate impact on Black Americans and other minority communities. Ensuring that the best diagnostic tools are available to identify these diseases in patients earlier, when they are the most treatable, is essential.”